Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization

Autor: Patten, J.J., Keiser, Patrick T., Morselli-Gysi, Deisy, Menichetti, Giulia, Mori, Hiroyuki, Donahue, Callie J., Gan, Xiao, Valle, Italo do, Geoghegan-Barek, Kathleen, Anantpadma, Manu, Boytz, RuthMabel, Berrigan, Jacob L., Stubbs, Sarah H., Ayazika, Tess, O’Leary, Colin, Jalloh, Sallieu, Wagner, Florence, Ayehunie, Seyoum, Elledge, Stephen J., Anderson, Deborah, Loscalzo, Joseph, Zitnik, Marinka, Gummuluru, Suryaram, Namchuk, Mark N., Barabási, Albert-László, Davey, Robert A.

Publikováno v: In iScience 16 September 2022 25(9)

Diminished Capsule Exacerbates Virulence, Blood–Brain Barrier Penetration, Intracellular Persistence, and Antibiotic Evasion of Hyperhemolytic Group B Streptococci

Autor: Gendrin, Claire, Merillat, Sean, Vornhagen, Jay, Coleman, Michelle, Armistead, Blair, Ngo, Lisa, Aggarwal, Anjali, Quach, Phoenicia, Berrigan, Jacob, Rajagopal, Lakshmi

Publikováno v: The Journal of Infectious Diseases, 2018 Apr 01. 217(7), 1128-1138.

Externí odkaz: https://www.jstor.org/stable/26494751

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

MPXV Infection Stimulates a More Robust and Durable Neutralizing Antibody Response Compared to MVA-BN Vaccination.

Autor: Selverian CN; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY, USA., Monticelli SR; Viral Immunology Branch, Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.; The Geneva Foundation, Tacoma WA, USA., Jaleta YM; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY, USA., Lasso G; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY, USA., DeMouth ME; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY, USA., Meola A; G5 Structural Biology of Infectious Diseases, Institut Pasteur, Université Paris Cité, Paris, France., Berrigan J; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY, USA., Batchelor TG; Viral Immunology Branch, Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.; Oak Ridge Institute of Science and Education, Oak Ridge, TN, USA., Battini L; G5 Structural Biology of Infectious Diseases, Institut Pasteur, Université Paris Cité, Paris, France., Guardado-Calvo P; G5 Structural Biology of Infectious Diseases, Institut Pasteur, Université Paris Cité, Paris, France., Herbert AS; Viral Immunology Branch, Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA., Chandran K; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY, USA., Meyerowitz E; Division of Infectious Diseases, Montefiore Medical Center, Bronx, NY, USA.; Albert Einstein College of Medicine, Department of Medicine, Bronx, NY, USA., Miller EH; Albert Einstein College of Medicine, Department of Microbiology and Immunology, Bronx, NY, USA.; Albert Einstein College of Medicine, Department of Medicine, Bronx, NY, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Oct 18. Date of Electronic Publication: 2024 Oct 18.

Crimean-Congo Hemorrhagic Fever Survivors Elicit Protective Non-Neutralizing Antibodies that Target 11 Overlapping Regions on Viral Glycoprotein GP38.

Autor: Shin OS; Adimab, LLC, Lebanon, NH 03766, USA., Monticelli SR; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA.; Geneva Foundation, Tacoma, WA 98042, USA., Hjorth CK; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA., Hornet V; Adimab, LLC, Lebanon, NH 03766, USA., Doyle M; Adimab, LLC, Lebanon, NH 03766, USA., Abelson D; Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA., Kuehne AI; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA., Wang A; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Bakken RR; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA., Mishra A; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA., Middlecamp M; Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA., Champney E; Adimab, LLC, Lebanon, NH 03766, USA., Stuart L; Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA., Maurer DP; Adimab, LLC, Lebanon, NH 03766, USA., Li J; Adimab, LLC, Lebanon, NH 03766, USA., Berrigan J; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Barajas J; Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA., Balinandi S; Uganda Virus Research Institute, Entebbe, Uganda., Lutwama JJ; Uganda Virus Research Institute, Entebbe, Uganda., Lobel L; Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel., Zeitlin L; Mapp Biopharmaceutical, Inc., San Diego, CA 92121, USA., Walker LM; Adimab, LLC, Lebanon, NH 03766, USA., Dye JM; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA., Chandran K; Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA., Herbert AS; U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA., Pauli NT; Adimab, LLC, Lebanon, NH 03766, USA., McLellan JS; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Mar 06. Date of Electronic Publication: 2024 Mar 06.